{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:52:50Z","timestamp":1790927570257,"version":"4.1.0"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1093\/sleep\/33.10.1295","type":"journal-article","created":{"date-parts":[[2017,2,5]],"date-time":"2017-02-05T15:43:28Z","timestamp":1486309408000},"page":"1295-1304","source":"Crossref","is-referenced-by-count":64,"title":["Dopaminergic Regulation of Sleep and Cataplexy in a Murine Model of Narcolepsy"],"prefix":"10.1093","volume":"33","author":[{"given":"Christian R.","family":"Burgess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Peever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t20170420082413_b1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/ncpneuro0300","article-title":"Narcolepsy and the hypocretin system--where motion meets emotion","volume":"2","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"key\n\t\t\t\t20170420082413_b2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","year":"2000","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170420082413_b3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","year":"2000","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170420082413_b4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1750-3639.2003.tb00033.x","article-title":"Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy","volume":"13","year":"2003","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170420082413_b5","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1212\/01.WNL.0000069608.84542.46","article-title":"Alteration of the striatal dopaminergic system in human narcolepsy","volume":"60","year":"2003","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170420082413_b6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/mds.20245","article-title":"Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting \u201csleep attacks\u201d","volume":"19","year":"2004","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170420082413_b7","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","year":"2007","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170420082413_b8","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","year":"2001","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170420082413_b9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0893-133X(99)00066-4","article-title":"Gammahydroxybutyrate and cocaine administration increases mRNA expression of dopamine D1 and D2 receptors in rat brain","volume":"21","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20170420082413_b10","first-page":"103","article-title":"Effect of gamma-hydroxybutyrate on central dopamine release in vivo","volume":"53","year":"1997","journal-title":"A microdialysis study in awake and anesthetized animals. Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170420082413_b11","first-page":"395","article-title":"Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat","volume":"95","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20170420082413_b12","first-page":"153","article-title":"Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats","volume":"3","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20170420082413_b13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0022-3565(25)38367-9","article-title":"Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat","volume":"266","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170420082413_b14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/jpet.103.053918","article-title":"Wake-promoting actions of dopamine D1 and D2 receptor stimulation","volume":"307","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170420082413_b15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1476-5381.1988.tb11715.x","article-title":"Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats","volume":"95","year":"1988","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170420082413_b16","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1097\/00001756-199911260-00046","article-title":"Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep","volume":"10","year":"1999","journal-title":"Neuroreport"},{"key":"key\n\t\t\t\t20170420082413_b17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nbd.2004.02.008","article-title":"The roles of midbrain and diencephalic dopamine cell groups in the regulation of cataplexy in narcoleptic Dobermans","volume":"16","year":"2004","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20170420082413_b18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(96)00541-0","article-title":"Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine","volume":"733","year":"1996","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20170420082413_b19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1523\/JNEUROSCI.2244-05.2006","article-title":"identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter","volume":"26","year":"2006","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170420082413_b20","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1523\/JNEUROSCI.0586-04.2004","article-title":"Behavioral state instability in orexin knock-out mice","volume":"24","year":"2004","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170420082413_b21","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1523\/JNEUROSCI.5151-08.2009","article-title":"Activity of pontine neurons during sleep and cataplexy in hypocretin knock-out mice","volume":"29","year":"2009","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170420082413_b22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","year":"1999","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170420082413_b23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02245159","article-title":"Involvement of dopamine receptor subtypes in mouse thermoregulation","volume":"107","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20170420082413_b24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1124\/jpet.104.074468","article-title":"Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1\/SvJ, C57BL\/6J, and DBA\/2J mice","volume":"312","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170420082413_b25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)09647-8","article-title":"Differential effects of direct and indirect dopamine agonists on the induction of gnawing in C57Bl\/6J mice","volume":"273","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170420082413_b26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(85)90429-7","article-title":"Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390","volume":"109","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20170420082413_b27","first-page":"32","article-title":"A Consensus Definition of Cataplexy in Mouse Models of Narcolepsy","year":"2009","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420082413_b28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2869.2004.00422.x","article-title":"The clinical spectrum of narcolepsy with cataplexy: a reappraisal","volume":"13","year":"2004","journal-title":"J Sleep Res"},{"key":"key\n\t\t\t\t20170420082413_b29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.smrv.2006.08.003","article-title":"The involvement of dopamine in the modulation of sleep and waking","volume":"11","year":"2007","journal-title":"Sleep Med Rev"},{"key":"key\n\t\t\t\t20170420082413_b30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0006-8993(87)91416-8","article-title":"A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis","volume":"401","year":"1987","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20170420082413_b31","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170420082413_b32","first-page":"49","article-title":"Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants","volume":"1","year":"1998","journal-title":"Sleep Res Online"},{"key":"key\n\t\t\t\t20170420082413_b33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/13543784.7.1.99","article-title":"modafinil: a novel stimulant for the treatment of narcolepsy","volume":"7","year":"1998","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t20170420082413_b34","first-page":"817","article-title":"Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs","volume":"18","year":"1995","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420082413_b35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1196\/annals.1369.064","article-title":"Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs","volume":"1074","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20170420082413_b36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","article-title":"Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes","volume":"38","year":"2003","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170420082413_b37","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1523\/JNEUROSCI.11-09-02666.1991","article-title":"Dopamine D2 mechanisms in canine narcolepsy","volume":"11","year":"1991","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170420082413_b38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","year":"1999","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170420082413_b39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0091-3057(87)90544-2","article-title":"Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat","volume":"26","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"key\n\t\t\t\t20170420082413_b40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1749-6632.1990.tb32015.x","article-title":"In vivo evidence for the existence of autoreceptors on dopaminergic, serotonergic, and cholinergic neurons in the brain","volume":"604","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20170420082413_b41","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0022-3565(24)37509-3","article-title":"Compensatory sleep responses to wakefulness induced by the dopamine autoreceptor antagonist (-)DS121","volume":"285","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170420082413_b42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02244337","article-title":"Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers","volume":"113","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20170420082413_b43","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1523\/JNEUROSCI.15-07-04806.1995","article-title":"Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy","volume":"15","year":"1995","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170420082413_b44","first-page":"511","article-title":"Cholinergic mechanisms in canine narcolepsy--I","volume":"59","year":"1994","journal-title":"Modulation of cataplexy via local drug administration into the pontine reticular formation. Neuroscience"},{"key":"key\n\t\t\t\t20170420082413_b45","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0306-4522(98)00600-9","article-title":"Locus coeruleus neurons: cessation of activity during cataplexy","volume":"91","year":"1999","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20170420082413_b46","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1113\/jphysiol.2003.052134","article-title":"Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs","volume":"554","year":"2004","journal-title":"J Physiol"},{"key":"key\n\t\t\t\t20170420082413_b47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1523\/JNEUROSCI.4015-04.2005","article-title":"Direct and indirect inhibition by catecholamines of hypocretin\/orexin neurons","volume":"25","year":"2005","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170420082413_b48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1152\/jn.01361.2005","article-title":"Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner","volume":"96","year":"2006","journal-title":"J Neurophysiol"},{"key":"key\n\t\t\t\t20170420082413_b49","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2004.10.005","article-title":"modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates","volume":"130","year":"2005","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20170420082413_b50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-2999(89)90817-0","article-title":"Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat","volume":"169","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20170420082413_b51","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0893-133X(00)00140-8","article-title":"Sulpiride, a D2\/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy","volume":"23","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20170420082413_b52","first-page":"A0052","article-title":"Noradrenergic Modulation of Muscle Tone During Cataplexy in Hypocretin\/Orexin Knockout Mice","volume":"32","year":"2009","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420082413_b53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-0102(00)00195-4","article-title":"Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans","volume":"38","year":"2000","journal-title":"Neurosci Res"},{"key":"key\n\t\t\t\t20170420082413_b54","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/brain\/123.6.1155","article-title":"Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls","volume":"123","year":"2000","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170420082413_b55","article-title":"Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo(11)C-raclopride PET study","volume-title":"Exp Neurol","year":"2008"},{"key":"key\n\t\t\t\t20170420082413_b56","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","article-title":"Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease","volume":"130","year":"2007","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170420082413_b57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1586\/14737175.5.5.581","article-title":"Pramipexole in the treatment of Parkinson's disease: new developments","volume":"5","year":"2005","journal-title":"Expert Rev Neurother"},{"key":"key\n\t\t\t\t20170420082413_b58","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.sleep.2006.03.018","article-title":"Use of pramipexole in REM sleep behavior disorder: results from a case series","volume":"7","year":"2006","journal-title":"Sleep Med"},{"key":"key\n\t\t\t\t20170420082413_b59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00023210-200721050-00008","article-title":"Pramipexole: in restless legs syndrome","volume":"21","year":"2007","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t20170420082413_b60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2165\/00023210-200519090-00005","article-title":"modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea\/hypopnoea syndrome and shift work sleep disorder","volume":"19","year":"2005","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t20170420082413_b61","article-title":"modafinil for Parkinson's disease fatigue","volume-title":"J Neurol","year":"2009"},{"key":"key\n\t\t\t\t20170420082413_b62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/14728214.6.2.239","article-title":"Medications for the treatment of narcolepsy","volume":"6","year":"2001","journal-title":"Expert Opin Emerg Drugs"},{"key":"key\n\t\t\t\t20170420082413_b63","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0028-3908(99)00131-8","article-title":"Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors","volume":"38","year":"1999","journal-title":"Neuropharmacology"}],"container-title":["Sleep"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/sleep\/article-pdf\/33\/10\/1295\/13689671\/sleep-33-10-1295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:42:03Z","timestamp":1749948123000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article-lookup\/doi\/10.1093\/sleep\/33.10.1295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/33.10.1295","relation":{},"ISSN":["1550-9109","0161-8105"],"issn-type":[{"value":"1550-9109","type":"electronic"},{"value":"0161-8105","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}